Actively Recruiting
Development and Evaluation of a Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice: A Cluster Randomized Trial
Led by University of Copenhagen · Updated on 2024-12-27
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Copenhagen
Lead Sponsor
K
Kvalitet i Almen Praksis (KiAP)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prostate cancer is the most common cancer among men in Denmark, often developing slowly without symptoms. This trial evaluates a complex intervention designed to improve how general practitioners (GPs) use prostate specific antigen (PSA) tests in line with national guidelines. The goal is to reduce overdiagnosis and overtreatment caused by unnecessary PSA testing, by promoting evidence-based practice among GPs in quality clusters. The intervention involves a cluster package including a pre-recorded podcast for GPs, a two-hour cluster meeting with educational material and group discussions, and two sets of hand-outs to support GPs in their clinics. Quality clusters are randomized to either receive this intervention over six months or act as a control group, which will be offered the intervention afterward. Participants, who are quality clusters of GPs, will be involved in cluster meetings and use the provided materials. Researchers will measure changes in PSA testing frequency among men during the six-month intervention period, as well as variations between GPs. The study includes assessments of PSA test use before and after the intervention to evaluate its impact on clinical practice.
CONDITIONS
Brief Title
A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Quality clusters with a cluster coordinator
- Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025
You will not qualify if you...
- Quality clusters who already planned their cluster meetings in 2025
- Quality clusters unwilling to await allocation before planning their cluster meetings in 2025
- Quality clusters participating in the pilot study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants in the intervention group engage in a cluster package intervention including a pre-recorded podcast, a two-hour cluster meeting about PSA testing, and receive hand-out materials to support evidence-based practice in their clinics.
1 to 4 cluster meetings over 6 months depending on cluster schedule
Duration - Up to 6 months following the intervention
Participants are observed for changes in PSA testing behavior following the intervention period.
No required visits; data collected from routine clinical practice
Trial Site Locations
Total: 1 location
1
Center of General Practice, Department of Public Health, University of Copenhagen
Copenhagen, Denmark
Actively Recruiting
Research Team
C
Christian Leick, PhD student
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here